Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-10

Clinical Trial Update: Roflumilast In-Vitro Basophil Release

View source ↗

Summary

A completed clinical trial update evaluating roflumilast's effect on basophil release in vitro in individuals with allergy or asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daliresp (roflumilast)
  • Roflumilast (roflumilast)

Snippet

Sponsor: Creighton University | Conditions: Allergy, Asthma | Status: COMPLETED